The Nasdaq Biotechnology Index fell by more than 1%. Among the constituent stocks, Lyell Immunopharma dropped 11.28%, Vor Biopharma fell 8.16%, Alumis decreased 6.99%, and Oruka Therapeutics declined 7.93%. Meanwhile, Coherus BioSciences rose 6.34%, Pyxis Oncology increased 8.02%, Ultragenyx Pharmaceutical gained 13.59%, and Jyong Biotech surged 43.38%

The Nasdaq Biotechnology Index fell over 1%. Component stocks Lyell Immunopharma dropped 11.28%, Vor BioPharma fell 8.16%, Alumis decreased 6.99%, and Oruka Therapeutics was down 7.93%, currently ranking fourth from the bottom. Coherus BioSciences rose 6.34%, Pyxis Oncology increased 8.02%, Ultragenyx Pharmaceutical climbed 13.59%, and Jyong Biotech surged 43.38%